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Background
The serotonin transporter (SERT) is responsible for the
rapid termination of neurotransmission by removing
serotonin from the synaptic cleft. We have explored the
functional significance of a highly conserved threonine
residue, at position 81, located within the amino-termi-
nus of SERT.
Methods and results
Our findings indicate that, although the mutated trans-
porters are normally targeted to the plasma membrane,
they exhibit marked functional defects, such as: (i) a dra-
matic decrease in amphetamine-induced efflux (despite
retaining normal amphetamine-induced currents), (ii) a
3-fold reduction in transporter turnover numbers (indi-
cating impaired substrate translocation) and (iii) a 4-fold
decrease in inhibitor affinity (due to a declined on-rate
and an enhanced off-rate). The latter suggests that the
mutated SERTs have a preference for inward-facing trans-
porter conformations, as further supported by our molec-
ular dynamics simulation experiments. By studying
several H-bond and hydrophobic interactions of the wild-
type T81, compared to its mutations to alanine or aspar-
tate, structural changes were detected in the juxtamem-
brane N-terminus region of SERT. The computer models
demonstrate a degradation of N-terminus interactions
with IL2 and IL3 (which are likely involved in the transi-
tion between inward- and outward-facing SERT confor-
mations) and a shift of the C-terminus away from the N-
terminus upon mutation. Moreover, truncation of the first
64 residues of the amino-terminus results in functional
defects comparable to the sole mutation of T81.
Conclusion
Hence, alterations in the amino-terminus region of SERT
induce inward-facing transporter states, causing hin-
drance to conformational changes required for ampheta-
mine-stimulated release, without simultaneously
obstructing the transporter's ability to operate in its chan-
nel or uptake mode of action.
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